Courtney L. Jones

Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia

Daniel A. Pollyea, Brett M. Stevens, Courtney L. Jones et al. · Nature Medicine · 2018 · 768 citations · Full text

Hematological Malignancy, Medicine, Acute Myeloid Leukemia +9

Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells

Courtney L. Jones, Brett M. Stevens, Angelo D’Alessandro et al. · Cancer Cell · 2018 · 539 citations · Full text

Hematological Malignancy, Biochemistry, Medicine +5

Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia

Shanshan Pei, Daniel A. Pollyea, Annika Gustafson et al. · Cancer Discovery · 2020 · 518 citations

Mixed-phenotype Acute Leukemia, Immunology, Pharmacotherapy +19

The TP53 Apoptotic Network Is a Primary Mediator of Resistance to BCL2 Inhibition in AML Cells

Tamilla Nechiporuk, Stephen E. Kurtz, Olga Nikolova et al. · Cancer Discovery · 2019 · 358 citations · Full text

Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells

Brett M. Stevens, Courtney L. Jones, Daniel A. Pollyea et al. · Nature Cancer · 2020 · 282 citations · Full text

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Hematology +6